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Abstract
The Sonic hedgehog (SHH)-signalling pathway mediates epithelial–mesenchymal interactions in several tissues during development and
disease, and we have investigated its role in rat ventral prostate (VP) development. We have demonstrated that Shh and Ptc expression
correlates with growth and development of the prostate and that their expression is not regulated by androgens in the VP. Prostatic budding
was induced in response to testosterone in Shh null mouse urogenital sinus (UGS) explants grown in vitro and in rat UGS explants cultured
with cyclopamine, suggesting that SHH-signalling is not critical for prostatic induction. SHH-signalling was disrupted at later stages of VP
development (in vitro), resulting in a reduction in organ size, an increase in ductal tip number, and reduced proliferation of ductal tip
epithelia. The addition of recombinant SHH to VPs grown in vitro caused a decrease in ductal tip number and expansion of the mesenchyme.
In the presence of testosterone, inhibition of SHH-signalling accelerated the canalisation of prostatic epithelial ducts and resulted in ducts
that showed morphological similarities to cribiform prostatic intraepithelial neoplasia (PIN). The epithelia of these ducts also demonstrated
precocious and aberrant differentiation, when examined by immunohistochemistry for p63 and cytokeratin 14. In conclusion, we show that
SHH-signalling is not essential for prostatic induction, but is important for prostatic growth, branching, and proliferation, and that
androgen-stimulated growth in the absence of signalling from the SHH pathway results in aberrant epithelial differentiation.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
The Sonic hedgehog (SHH)-signalling pathway regulates
epithelial–mesenchymal interactions during the develop-
ment of many organs. SHH is synthesised in epithelial cells,
and in many situations, acts as a paracrine factor through its
receptor Patched1 (PTC) that is expressed in adjacent mes-
enchymal cells. Shh null mice exhibit various developmen-
tal defects, including cyclopia, neural tube defects, and
absence of distal limb structures (Chiang et al., 1996).
Inhibition of SHH-signalling using cyclopamine (Cy) has
demonstrated its role in development of the neural tube
(Incardona et al., 1998), gastrointestinal tract (Sukegawa et
al., 2000), pancreas (Kim and Melton, 1998), and in hair
follicle morphogenesis (Chiang et al., 1999). SHH-signal-
ling is also required for branching morphogenesis of the
lung (Bellusci et al., 1997; Pepicelli et al., 1998). Shh
transcript expression has been reported in the urogenital
sinus (UGS) epithelium (Bitgood and McMahon, 1995),
where it is required for the formation of external genitalia
(Haraguchi et al., 2001; Perriton et al., 2002), and has
recently been implicated in prostate development (Lamm et
al., 2002; Podlasek et al., 1999).
Reciprocal mesenchymal–epithelial interactions play a
key role in directing growth of the prostate during develop-
ment and disease (Cunha et al., 1996; Marker et al., 2003).
Under normal developmental conditions epithelial growth is
controlled through androgen-regulated signalling in the
mesenchyme (Cunha and Chung, 1981; Gao et al., 2001).
* Corresponding author. Fax: 44-131-242-6231.
E-mail address: axel.thomson@hrsu.mrc.ac.uk (A.A. Thomson).
R
Available online at www.sciencedirect.com
Developmental Biology 264 (2003) 352–362 www.elsevier.com/locate/ydbio
0012-1606/$ – see front matter © 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2003.08.018
Conversely, paracrine signalling from the epithelium pat-
terns stromal differentiation during prostate development
and maintains the mesenchyme/stroma in the adult prostate
(Cunha et al., 1996). Little is known about the pathways that
regulate mesenchymal–epithelial interactions in prostatic
growth; however, a role for the SHH-signalling pathway has
been established. The importance of SHH-signalling in
prostatic growth was first demonstrated by antibody block-
ade of SHH, which abrogated growth of the prostate from
male UGS tissue transplanted into male host mice (Podlasek
et al., 1999). Podlasek et al. also reported that Shh transcript
expression was upregulated in the male UGS in response to
androgens, concluding that androgen-induced expression of
Shh in the UGS is necessary for prostatic induction. More
recently, Lamm et al. (2002) demonstrated that inhibition of
SHH-signalling in mouse UGS explants, cultured using
both anti-SHH antibody and cyclopamine, reduced ductal
budding concurrent with reduced expression of Gli1, a tran-
scriptional mediator of SHH-signalling. This work also sug-
gested that androgens induce a male-specific pattern of Shh
expression. However, our data on SHH-signalling in pros-
tate development do not concur with some aspects of these
studies. We have addressed the role of SHH-signalling in
prostate organogenesis, by detailed analysis of Shh and Ptc
transcript expression and regulation. We have grown Shh
null mouse UGS explants in vitro, disrupted the SHH-
signalling pathway in rat UGS explants, and inhibited and
supplemented the SHH-signalling pathway in rat VPs. Our
results suggest that Shh and Ptc transcript expression is not
dependent on androgens and, while not required for pros-
tatic induction, SHH-signalling is important in later stages
of prostate development. Furthermore, we have demon-
strated that inhibition of SHH-signalling during VP growth
affects epithelial growth, patterning, and differentiation, and
results in prostatic epithelial ducts showing morphological
appearances similar to human cribiform prostatic intraepi-
thelial neoplasia (PIN).
Materials and methods
Tissue isolation
Whole urogenital tracts (UGTs), VPs, and urethras
(URs) were microdissected from either outbred Wistar rats
or Shh null mice or littermates, on an outbred CD1 back-
ground (Chiang et al., 1996), where the day of copulatory
plug observation was taken as e0.5, and day of birth was
designated P0.
RNase protection assays
Total RNA was prepared as described (Chomczynski and
Sacchi, 1987). DNA templates for Shh and Ptc riboprobes
were synthesised by RT-PCR from P0 UGT cDNA and
subcloned into pBluescript KSII (Stratagene, USA). PCR
primers were designed by using GenBank-published cDNA
sequences (Shh: GenBank Accession No. NM_017221;
Primers: L-ACCGCAGCAAGTATGGCA, R-TCCAG-
GAAGGTGAGGAAG; Ptc: GenBank Accession No.
AF079162; Primers L-GCATTGGCAGGAGGAGTTGAT-
TGTG, R-CCACTCGGATGACACTGACA). DNA tem-
plates for Cyclophilin (Cphn) and 28S riboprobes were from
Ambion, Inc., USA. 32P-labelled anti-sense riboprobes were
transcribed, and RNase protection assays performed as pre-
viously described in detail (Thomson and Cunha, 1999).
RNase protected products from Shh, Ptc, Cphn, and 28S
riboprobes were 269, 322, 103, and 155 nt, respectively.
Gels were imaged by using a Storm PhosphorImager (Mo-
lecular Dynamics, USA), and transcript abundance was de-
termined from the intensities of bands, calculated using
ImageQuant V.1.2 (Molecular Dynamics, USA). Transcript
abundances were normalised to either Cphn or 28S internal
standards (28S was used as an internal standard in postnatal
samples as Cphn expression was found to decrease with
age).
In situ hybridisation
In situ hybridisation was performed on 7-m paraffin-
embedded sections by using a procedure slightly modified
from previously described protocols (Frohman et al., 1990;
Thomson and Cunha, 1999). 33P-labelled anti-sense and
control sense riboprobes were synthesised by using the
same Shh DNA template and method as for RNase protec-
tion assays. Slides were dipped in G.5 emulsion (Ilford, UK)
and developed according to manufacturer’s instructions.
Dark field images were inverted, their grains coloured red,
and overlayed with bright field images using Adobe Photo-
shop software.
Organ culture
Serum-free organ culture was performed as previously
described (Thomson and Cunha, 1999). Culture media was
supplemented with 108 M testosterone and/or either 1, 5,
or 10 M cyclopamine (kindly provided by W. Gaffield), or
100 g ml1 anti-SHH antibody (clone 5E1, Developmen-
tal Studies Hybridoma Bank, University of Iowa), or 0.2 g
ml1 recombinant SHH protein (Research Diagnostics,
USA). NIH Image software was used to trace around the
perimeter of images of VPs grown in vitro, giving a mea-
surement of organ perimeter in pixels. The two-dimensional
area of organs was calculated by using NIH Image software,
by quantifying the number of square pixels contained within
the measured organ perimeter.
Histology
The histology of sections was examined either by
trichrome or haematoxylin staining. For CK14 and p63
immunostaining, with diamino benzamide (DAB) detection,
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sections were pressure-cooked in 10 mM citric acid, pH 6.0,
for 2 min before following a previously published protocol
(Thomson et al., 2002). Anti-CK14 antibody (a gift from B.
Lane) was diluted 1:100, and anti-p63 antibody (Santa Cruz
Biotechnologies Inc., USA) was diluted 1:500. BrdU and
pan-cytokeratin colocalisation immunohistochemistry was
performed as previously described (Thomson et al., 2002),
using 1:300 dilution of anti-BrdU antibody (Fitzgerald In-
dustries International Inc., USA) and 1:200 dilution of anti-
pan-cytokeratin antibody (Sigma, UK). BrdU was detected
with Alexofluor 488 (Molecular Probes Inc., USA) and
pan-cytokeratin was detected with Cy5 (Amersham Bio-
sciences, UK). Proliferative indices were calculated by
counting the number of pan-cytokeratin-positive epithelial
cells or pan-cytokeratin-negative mesenchymal cells that
were also BrdU-positive.
Results
Shh mRNA expression in the male UGT
Shh transcripts were localised to the urethral epithelium
(URE), and epithelia of the developing ventral prostate
(VPE), dorsal prostate (DPE), and dorsolateral prostate
(DLPE) of P0 male UGTs by in situ hybridisation (Fig. 1A
and B). Signal intensities appeared similar along the length
of prostatic buds and between prostatic buds and URE. Shh
transcripts were not observed in the stroma of the UGT. No
signal was observed by using a control sense riboprobe
(data not shown).
Shh and Ptc mRNA levels were also examined by RNase
protection assay (RPA). Shh and Ptc mRNAs were most
abundant at e18.5 in the UGT (Fig. 1C). Transcript levels
were low between e19.5 and e21.5, but were elevated at P0.
Shh and Ptc mRNA expression was higher in the VP than
the UGT at P0, which may have been due to variation in the
proportions of epithelium in these tissues. In the postnatal
VP, Shh and Ptc transcript levels decreased with increasing
age (Fig. 1D). Shh and Ptc mRNAs were most abundant at
P0 and P2, but by P6 these levels were four-fold lower than
at P0. Shh and Ptc mRNAs were almost undetectable at P20
and absent in adults. A comparison of Shh and Ptc transcript
levels in postnatal VPs and URs (urethras) showed tran-
scripts to be more abundant in VPs than URs until P2, but
by P4 this situation was reversed (Fig. 1E). Unlike the VP,
expression in the UR was maintained beyond P20, separat-
ing the developmental pathways of these structures.
Shh mRNA expression is not androgen-regulated in the VP
As prostate development occurs only in males, and male-
specific upregulation of Shh mRNA in the mouse UGS had
been reported (Podlasek et al., 1999), Shh and Ptc transcript
levels were compared between male and female rat UGTs
(Fig. 1F). RPA analysis showed Shh and Ptc mRNA ex-
pression was approximately 2.5-fold higher in females than
males at e17.5, while at P0 and P6, transcript levels were
similar between sexes. At P20, expression of Shh and Ptc
transcripts was minimal in the male but still maintained in
the female.
Shh and Ptc transcripts levels were analysed in VPs and
URs grown in vitro with or without androgens. VPs were
cultured for 6 days / T (testosterone); or for 5 days with
T followed by a 1 day treatment with the AR antagonist
cyproterone acetate (CA) (Fig. 1G). No significant differ-
ence in transcript abundance was noted for Shh or Ptc.
Similarly, in short-term cultures of VPs (7 h or 3 days), no
change in transcript levels was observed (data not shown).
Analysis of transcript levels in the microdissected URs of
female UGTs cultured for 3 days/ T revealed a 2.5-fold
upregulation of Shh transcripts (Fig. 1H), although no sig-
nificant change in Ptc transcript levels was observed.
HH-signalling is not required for prostatic induction
UGTs were microdissected from e17.5 Shh null mice and
examined; Shh null mice UGTs were smaller than those of
their wild-type littermates (not shown), and the hindgut was
contiguous with the bladder (Fig. 2A). As the prostate was
not well developed in either mutant (Fig. 2B) or wildtype
males at this stage, UGS explants from both Shh null mice
and their littermates were grown in vitro to determine
whether prostatic budding could be induced (n  3). Pros-
tatic buds were present after 3 days and appeared enlarged
after 5 days in both Shh null (Fig. 2C) and littermate UGS
explants (not shown). Indian hedgehog (Ihh) is expressed in
the VP at much lower levels than Shh by RT-PCR (data not
shown), and it was possible that an upregulation of Ihh (or
another Hh family member) may have compensated for lack
of SHH in Shh null UGT explants. Therefore, e16.5 rat UGS
explants were grown in vitro for 7 days / T and / 1,
5, or 10 M cyclopamine (Cy) (n  4), which blocks
signalling via Smoothened and thus all Hh family ligands
(Chen et al., 2002; Incardona et al., 1998). Prostatic buds
were not observed in explants grown T (Fig. 2D); pros-
tatic buds were present in explants grown T (Fig. 2E) and
T 1 M Cy (Fig. 2F) at similar levels. Prostatic buds
were also present in explants grownT5 M Cy andT
10 M Cy (data not shown), though these concentrations
of Cy were toxic and caused premature organ death.
HH-signalling is involved in VP growth and branching
Next, the role of HH-signalling in prostate growth and
branching morphogenesis was examined. P0 rat VPs were
cultured for 6 days /T, and /Cy (Fig. 3A), and their
2D area was measured (n  21, 100 VPs from each of 4
treatment groups) (Fig. 3B). The optimum concentration of
Cy for growth inhibition was 1 M; 0.1 M Cy showed
little or no effect and 10 M Cy appeared to be toxic.
Disruption of HH-signalling significantly inhibited VP
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growth in the presence or absence of T. The addition of Cy
to organs cultured T resulted in a growth reduction of
16% (T vs T Cy; Student’s t test, P  3.0e14), and
Cy reduced the growth of VPs cultured T by 27% (T vs
T Cy; Student’s t test, P  1.4e34).
The number of peripheral epithelial bud tips was counted
in VPs cultured /T /Cy (n  16, 60 VPs from each
of 4 treatment groups) (Fig. 3C). The addition of Cy to
organs cultured T caused a significant increase in the
number of peripheral tips per unit perimeter (T  60.16
/ 0.97 mean bud tips per unit perimeter/T Cy 
74.47 / 1.07; Student’s t test, P  1.31e17), the in-
crease in tip number observed T Cy was similar to T
(T  71.80 / 0.83). VPs grown T Cy showed
fewer peripheral tips, when compared with those cultured
T (T Cy  69.84 / 1.13); however, this reduction
showed a low statistical significance (Student’s t test, P 
0.08).
BrdU incorporation was used to calculate a proliferative
index in VPs grown /T and /Cy (Fig. 3D) (n  4, 9
organs in each treatment group). There was a significant
reduction in stroma in VPs grown TCy, which pre-
cluded accurate calculation of proliferative index of organs
in this group. A proliferative index was calculated for the
epithelium by colocalisation of BrdU with pan-Cytokeratin.
The percentage of proliferating epithelial cells was scored
from 3 images of the peripheral edges of the organs (distal),
and 3 images of the ducts closest to the urethra (proximal),
totalling 27 distal and proximal counts for each treatment
group. A 30% reduction in proliferation was observed in the
distal epithelial tips of organs cultured Cy, both /T
(T  18.92% / 1.48% proliferative nuclei; T Cy
 13.48% / 0.93%, Student’s t test, P  0.002; T 
23.24% / 1.86%; T Cy  16.28% / 0.74%,
Student’s t test, P  0.0005). No significant difference was
observed in the percentage of proliferating cells in the ducts
proximal to the UR in response to Cy.
Inhibition of SHH-signalling affects canalisation and
differentiation of prostatic epithelial ducts
Prostatic ducts develop and grow as solid cords, which
subsequently canalise. Canalisation occurs in a proximal-
to-distal direction (from the UR outwards), and may be the
result of epithelial cell differentiation (Hayward et al., 1996;
Wang et al., 2000). After growth in vitro, lumens are present
in the ducts proximal to the UR (Fig. 4G), but not in the
distal tips. Lumens were observed in the proximal ducts of
VPs in all treatment groups, but VPs cultured T Cy also
exhibited lumens in almost all distal tips (Fig. 4J–L). The
architecture of the peripheral ducts of VPs cultured T
Cy was not normal but had a cribiform appearance, with
epithelial bridging suggesting multiple lumens and some
expansion of the duct.
Undifferentiated prostatic epithelial cells at growing tips
uniformly express cytokeratin 14 (CK14) (Hayward et al.,
1996) and p63 (Parsons et al., 2001; Wang et al., 2000). As
epithelial cells differentiate, expression of CK14 and p63
becomes confined to the basal cell layer (Hayward et al.,
1996; Parsons et al., 2001; Wang et al., 2000). We investi-
gated CK14 and p63 localisation in VPs grown in vitro
Fig. 1. Analysis of Shh transcript expression. Shh transcripts (red) were
localised to the epithelium of P0 rat UGTs by in situ hybridisation. (A)
shows UR, VP, and SV (seminal vesicles). (B) shows a higher magnifica-
tion of (A), with Shh transcripts (red) in the urethral epithelium (URE), VP
epithelium (VPE), and dorsolateral prostate epithelium (DLPE). Shh and
Ptc transcript expression was analysed by RNase protection assay (RPA) in
rat embryonic UGT (C) and postnatal VP (D), and was compared between
postnatal VP and UR (E) and male and female UGTs (F). Androgen
regulation of Shh and Ptc transcripts was investigated in VPs (G) and URs
(H) grown in vitro. tRNA samples were included in all RPAs as negative
hybridisation controls.
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/T and /Cy. p63 expression was abundant in the
epithelial cells of distal tips of organs cultured T, T
Cy, and T (Fig. 4B, E, and H). The majority of distal
epithelial tips in these organs showed uniform p63 staining,
characteristic of the undifferentiated state, while in others
there was an increase in p63-positive cells towards the
basement membrane. By contrast, in VPs cultured T
Cy, p63 expression was confined to the basal cell layer of
all distal tips (Fig. 4K). p63 expression was localised to the
basal layer of epithelial cells in the proximal ducts of VPs
from all treatment groups. Expression of CK14 showed
similarities to p63, though less basal cells appeared CK14-
positive than p63-positive. The majority of distal tips in VPs
cultured T and T Cy (Fig. 4C and F) expressed CK14
broadly, in keeping with undifferentiated epithelial cells.
Distal tips with both uniform expression of CK14 and with
a defined layer of CK14-expressing basal cells were ob-
served in VPs cultured T (Fig. 4I). VPs cultured T Cy
exhibited very few CK14-positive cells in distal tips (Fig.
4L), contrasting with the relative abundance of p63-positive
cells. CK14 expression was confined to the basal cell layer
in the proximal ducts of VPs from all treatment groups.
Effect of exogenous SHH on VP growth and branching
The effects of adding recombinant SHH to VPs grown in
vitro was examined (Fig. 5). VPs were grown for 3 days
/T and / recombinant SHH protein (n  6). The
addition of SHH to cultures resulted in expansion of the
mesenchyme around the periphery of VPs, both / T
(Fig. 5A). Measurement of the 2D area of the cultured VPs
(n  6, 14 VPs from each treatment group) showed that the
addition of SHH caused a small reduction in overall VP
growth, both / T, that showed a low statistical signifi-
cance (T vs. T SHH % area  100 / 3.56 vs.
90.12 / 5.26, Student’s t test, P  0.07; T vs. T
SHH % area  127.05 / 5.12 vs. 123.03 / 6.75,
Student’s t test, P  0.32) (Fig. 5B).
The number of peripheral bud tips from the cultured VPs
was counted and expressed as a ratio to perimeter (Fig. 5C).
The addition of SHH to cultures significantly reduced the
number of peripheral bud tips both /T, thus having an
opposite effect to inhibiting HH-signalling with Cy (T vs.
T SHH mean bud tips per 1000 pixels perimeter 
68.65 / 2.62 vs. 48.09 / 3.35, Student’s t test P 
Fig. 2. Prostatic induction in Shh null mice and rat UGS grown in vitro with cyclopamine. (A) Whole UGT of e17.5 Shh null male mouse displaying urogenital
sinus (UGS), bladder (BL), and hindgut (HG). e17.5 Shh null male mouse UGS before (B) and after (C) growth in vitro for 5 days; arrows show prostatic
buds. e16.5 male rat UGS grown in vitro for 7 days either without media supplement (D), T (E), or T  Cy (F); arrows show prostatic buds. Scale bars
shown are 1 mm.
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3.13e5; T vs. T SHH  83.92 / 2.25 vs. 68.34
/ 2.57, Student’s t test P  5.37e5).
The proliferative index of the epithelial and mesenchy-
mal cell compartments was calculated for VPs cultured
/T and / SHH after the addition of BrdU (Fig. 5D).
Epithelial labelling index was calculated at day 3 of culture,
while mesenchymal labelling index was calculated on day 2
of culture, since our data indicated that effects on mesen-
chymal proliferation were more pronounced on day 2 com-
pared with day 3. In VPs grown T, SHH reduced epithe-
lial cell proliferation by a third (T vs. T SHH %
proliferative nuclei  27.95% / 1.15% vs. 18.62% /
2.06%, Student’s t test P 1.84e4), but by only 6% in VPs
grown T, which was not statistically significant (T vs.
T SHH % proliferative nuclei  32.54% / 1.65%
vs. 30.46% / 1.72%, Student’s t test P  0.19). In the
mesenchyme, SHH stimulated proliferation in the presence
or absence of T (T vs TSHH % proliferative nuclei 
14.96 / 0.89% vs. 19.45 / 1.12%, Student’s t test P
 0.002; T vs. TSHH % proliferative nuclei  17.81
/ 1.22% vs. 20.47 / 1.07%, Student’s t test P 
0.056).
Discussion
We have demonstrated that HH-signalling participates in
growth of prostatic mesenchyme and epithelium, and in
epithelial differentiation. Induction of prostatic budding, in
response to T, in Shh null mouse UGS explants grown in
vitro and in rat UGS explants cultured with Cy suggested
that HH-signalling is not required for the induction of pros-
tatic buds. However, inhibition of SHH-signalling during
later stages of VP growth and branching retarded growth of
VPs cultured in vitro, reduced epithelial proliferation, and
increased the number of ductal tips in prostatic epithelia. In
contrast, the addition of exogenous SHH to VPs grown in
vitro reduced the number of ductal bud tips and caused
mesenchymal expansion. In the presence of T, inhibition of
SHH-signalling caused aberrant differentiation of prostatic
epithelia that was reminiscent of PIN. We propose that
SHH-signalling is not essential for prostatic induction, but
is an important regulator of mesenchymal–epithelial inter-
actions during later stages of prostate growth and develop-
ment.
The temporal and spatial expression pattern of Shh in the
P0 male rat UGT suggested a role for Shh in prostatic
growth and development. Shh transcripts were localised to
the epithelia of the urethra and developing prostatic lobes, in
agreement with earlier studies of Shh transcript distribution
(Bitgood and McMahon, 1995; Lamm et al., 2002; Podlasek
et al., 1999). Shh transcript distribution appeared uniform
along the proximal–distal axis of the developing ducts, and
in the UGS epithelium. This differed from the observations
of Lamm et al., (2002), who reported elevated levels of Shh
Fig. 3. The effect of cyclopamine on VPs grown in vitro. VPs from P0 rats were grown in serum-free culture for 6 days / 108 M T / 106 M Cy.
(A) Whole-mount images of VPs on day 6 of culture. Scale bar, 1 mm. (B) Graph showing the mean 2D areas of cultured VPs relative to T / s.e.m.
(C) Graph showing the mean number of epithelial buds around the periphery of cultured VPs, expressed as a ratio to organ perimeter (mean buds per 1000
pixels perimeter / s.e.m.). (D) Graph showing the mean percentage of proliferating cells in epithelial buds / s.e.m.
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transcripts in the tips of growing ducts, and diminished
expression in the remainder of the UGS epithelium. We
propose that these differences result from section artifact, as
in some sections we only observed the tips of growing
epithelial buds, which expressed Shh. RPA analysis showed
Shh and Ptc transcripts to be most abundant at e18.5, cor-
relating with the visible outgrowth of the urethral epithe-
lium towards the ventral mesenchymal pad (VMP). Shh and
Fig. 4. The effect of cyclopamine on prostatic duct canalisation and epithelial differentiation. Sections of VPs, cultured for 6 days/T/Cy, were stained
with Masson’s trichrome (A, D, G, J) to examine prostatic duct morphology, and anti-p63 (B, E, H, K) or anti-cytokeratin 14 (CK14) (C, F, I, L) antibodies
to examine epithelial differentiation. (A–C) T; (D–F) T Cy; (G–I) T; (J–L) T Cy. Arrows mark lumens and asterisks mark the multiple lumens
in ducts with a cribiform appearance. Scale bars, 50 m.
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Ptc transcript levels were elevated again at P0, associating
with the surge of VP growth and branching that occurs in
the neonatal period. The temporal expression pattern of Shh
was in agreement with that of a recent study (Lamm et al.,
2002), and the ontogeny of Shh and Ptc expression in the
male UGT was found to reflect that of Gli1 (Lamm et al.,
2002), a transcriptional mediator of SHH-signalling, and
Bmp4, which is expressed in the mesenchyme surrounding
the growing epithelial buds of the prostate (Lamm et al.,
2001). In the postnatal VP, high levels of Shh and Ptc
transcripts were observed in the early neonatal period of
growth and branching. These levels declined after P6 so that
transcripts were almost undetectable by P20, when VP
growth slows significantly until quiescence in adulthood.
The temporal expression pattern of Shh and Ptc in the VP
correlates with that of Fgf10, which, like Bmp4, is expressed
in the mesenchyme surrounding growing epithelial buds
(Thomson and Cunha, 1999).
A comparison of Shh and Ptc transcript levels between
the VP and UR of postnatal males revealed that, while
transcript levels decreased in the VP approaching adult-
hood, expression in the UR was maintained at a similar level
throughout development. These data suggest that SHH-
signalling is required for growth and branching in the VP,
and we propose that maintained SHH-signalling in the UR
may be required for continued elongation of the UR into
adulthood, or for the formation of urethral glands. Our data
also suggest that high levels of Shh transcripts reported in
the postnatal male mouse UGS (Podlasek et al., 1999) may
have originated from the UR, and contrast with data sug-
gesting that Shh transcripts are diminished in the UR rela-
tive to prostatic buds in neonates (Lamm et al., 2002).
Comparisons of transcript levels between the male and
female UGTs demonstrated that there was more Shh and Ptc
mRNA in females than males, suggesting that direct andro-
gen-regulation of these transcripts is unlikely. Our data were
found to contradict that of Podlasek et al. (1999), who
reported 7-fold higher expression of Shh in male UGS than
female UGS of e19 mice (Podlasek et al., 1999). As we used
RNase protection assays to quantify transcript levels, it is
likely that our data are more accurate, though different
microdissection techniques and species-specific differences
cannot be ruled out. In support of these data, no significant
difference in Shh and Ptc transcript levels was observed
between VPs grown in vitro with or without T. Addition-
ally, Podlasek et al. (1999) reported a 5-fold increase in Shh
transcripts in e15 male mouse UGS explants cultured for 3
days with dihydrotestosterone. In agreement with this, we
Fig. 5. The effect of exogenous recombinant SHH protein on VPs grown in vitro. VPs from P0 rats were grown in vitro for 3 days / T / recombinant
SHH. (A) Whole-mount images of VPs on day 3 of culture. Scale bar, 1 mm. (B) Graph showing the mean 2D areas of cultured VPs relative to T /
s.e.m. (C) Graph showing the mean number of epithelial buds around the periphery of cultured VPs, expressed as a ratio to organ perimeter (mean buds per
1000 pixels perimeter / s.e.m.). (D) Graph showing the mean percentage of proliferating cells in distal epithelial buds (at 3 days) and surrounding
mesenchyme (at 2 days) / s.e.m.
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observed a 2.5-fold upregulation of Shh expression in re-
sponse to T in the URs of female UGTs. Surprisingly, there
was no upregulation of its receptor, Ptc, bringing into ques-
tion the functional significance of this observation.
The emergence of prostatic buds in UGS explants from
Shh null mice and rat UGS explants grown with Cy sug-
gested that Shh (or Ihh or Dhh) is not critical for prostatic
induction. Our results concur with experiments showing
that when mouse UGS explants were cultured in the pres-
ence of 1 M Cy, prostatic budding was not inhibited
(Lamm et al., 2002). However, Lamm et al. (2002) reported
inhibition of budding in UGS explants cultured with 5 and
10 M Cy; these concentrations of Cy caused extensive
mesenchymal degeneration and early death of our UGS
explants. We therefore propose that the presence of fewer
prostatic buds at these concentrations of Cy was not due to
direct inhibition of budding, but due to toxic effects of high
Cy concentrations. This is supported by a recent study that
showed 10 M Cy resulted in significant cell death in VP
explant cultures (Wang et al., 2003), though lower concen-
trations were non-toxic.
Nkx3.1 is the earliest known marker of prospective pros-
tatic epithelium, and is expressed 2 days prior to the ap-
pearance of prostatic buds (Bhatia-Gaur et al., 1999).
Nkx3.1 is not required for prostatic induction, since Nkx3.1
null mutants still have a prostate (Bhatia-Gaur et al., 1999;
Schneider et al., 2000), but its expression is required for
epithelial differentiation during development, and correct
function of the prostate during adulthood (Bhatia-Gaur et
al., 1999). As Nkx3.1 is expressed in the male (but not the
female) UGS, it is likely to be androgen-regulated, and as
expression occurs before functional AR appears in the ep-
ithelium, this androgen-regulation is likely to be mediated
via the mesenchyme (Bhatia-Gaur et al., 1999). Previous
studies have observed that Shh null mice do not express
Nkx3.1 in the UGS (Schneider et al., 2000), and current
literature supports a hypothesis in which androgens upregu-
late Shh expression in males (Podlasek et al., 1999) and
elicit a male-specific expression pattern (Lamm et al.,
2002), which in turn induces Nkx3.1 expression. However,
our finding that Shh transcripts are found in the UGS of both
males and females, and are not upregulated in males, and
recent data showing that Nkx3.1 expression is found in Shh
null explant cultures and tissue recombinants (D. Berman,
X. Desai, C. Wang, C. Abate-Shen, P. Beachy, M.M., Shen,
unpublished observations) suggest that Shh is not required
for Nkx3.1 expression in the male UGS during prostatic
induction. We also conclude from our data that Shh expres-
sion is not a prerequisite for prostatic induction.
A direct role for SHH was demonstrated in later stages of
VP growth and development by inhibition and supplemen-
tation of the SHH-signalling pathway. Blocking SHH-sig-
nalling using both anti-SHH antibody (data not shown) and
Cy resulted in a reduction in size of VPs and an increase in
epithelial bud tip number. Growth effects resulting from
antibody blockade confirmed that, during VP growth and
development, signalling via SMO is dependent on SHH as
a ligand. In contrast, the addition of rSHH to VPs grown in
vitro had little effect on final organ size, but reduced epi-
thelial bud tip number.
Both inhibiting SHH-signalling or adding rSHH to VPs
grown in vitro affected prostatic mesenchyme. Although not
directly quantified, there appeared to be a smaller proportion
of mesenchyme in VPs cultured with Cy, which made cal-
culation of a proliferative index not possible for this cell
compartment. In VPs grown with recombinant SHH, a
greater proportion of mesenchyme was apparent (Fig. 5A)
and an increase in proliferative rate was observed (Fig. 5D).
Thus, we propose that SHH-signalling is a regulator of
prostatic mesenchymal cell proliferation. It appears that
SHH is also a mitogen in kidney mesenchyme (Yu et al.,
2002), which suggests that SHH may function as regulator
of mesenchymal proliferation in several urogenital tissues.
Counting the distal epithelial buds tips of the cultured
VPs revealed that inhibiting SHH-signalling increased distal
bud tip number and rSHH reduced distal bud tip number,
with both treatments reducing epithelial mitogenesis. In
mesenchyme-free lung explants, increased epithelial cell
proliferation is not required for branching but is required for
elongation (Nogawa et al., 1998). We propose that inhibit-
ing SHH-signalling increased bud tip number in cultured
VPs by reducing mitogenesis and augmenting branching
morphogenesis. This would suggest that in vivo SHH acts to
inhibit branching and allow elongation of epithelial bud
tips. We propose that the reduction in bud tip number in VPs
cultured with rSHH was the result of branching inhibition.
A significant increase in the number of ductal tips and
branch points has also been observed in the VPs of Bmp4
haploinsufficient mice, and a decrease is observed when
exogenous BMP4 is added to UGS explant cultures (Lamm
et al., 2001). Bmp4 is postulated to inhibit lateral branching,
thereby allow elongation, of prostatic epithelial ducts
(Lamm et al., 2001). Shh and Bmp4 are expressed concur-
rently in adjacent epithelium and mesenchyme, respec-
tively, at several sites during development (Bitgood and
McMahon, 1995), and it has been demonstrated that Shh can
modulate the expression of Bmp4 (Haraguchi et al., 2001).
We suggest that Shh might operate upstream of Bmp4 in a
pathway that inhibits branch formation in the prostate.
We observed that canalisation had occurred at the distal
tips of VPs culturedTCy, whereas in VPs culturedT,
T Cy, and T, canalisation was only evident in proxi-
mal ducts. This suggested that in the presence of T inhibi-
tion of SHH-signalling accelerated canalisation, but that
disruption of SHH-signalling alone was not sufficient to
induce this effect. We propose that SHH-signalling inhibits
canalisation of prostatic epithelial ducts in vivo, and so
plays an opposing role to T, which promotes canalisation
(Hayward et al., 1996). The morphology of the distal tips of
VPs culturedTCy was complex, with a well-developed
cribiform pattern and multiple lumens. In human disease,
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this cribiform pattern can be seen in severe forms of benign
epithelial hyperplasias and in high-grade PIN, the precursor
of invasive carcinoma. In lesions of PIN, there is generally
a single layer of basal cells, often with large gaps, and an
expansion of the duct as in our VPs cultured T Cy (Fig.
4J–L). These observations suggest that prostatic epithelia of
our VPs, grown in vitro T Cy, recapitulate some of the
features of PIN.
There is a clear temporal and spatial relationship be-
tween canalisation of prostatic ducts and epithelial cell
differentiation. Immunohistochemistry for the basal cell
marker p63 revealed that the epithelia in all distal tips of
VPs cultured T Cy had differentiated. This suggested
that inhibition of SHH-signalling in the presence of T ac-
celerated epithelial cell differentiation. The expression pat-
tern of another basal cell marker, CK14, was similar to that
of p63, except that the majority of cells in the distal tips of
VPs culturedTCy failed to express CK14. The absence
of a complete layer of CK14-positive basal cells is well
recognised in human prostate, where variations in expres-
sion of keratin subtypes are well described (Freeman et al.,
2002). The functional significance of these variations in
keratin profile is unknown. Nevertheless, fewer CK-positive
cells are generally seen in PIN than in normal glands
(Bostwick and Brawer, 1987; P.H., personal observation),
and the relative paucity of CK14-positive cells in VPs
cultured T Cy is again reminiscent of PIN.
Inappropriate activation of the SHH-signalling pathway
has been implicated in several types of tumor (reviewed in
Ruiz i Altaba et al., 2002). Our data are novel in that
inactivation of the SHH-signalling pathway during growth
resulted in lesions suggestive of disease. The SHH-signal-
ling pathway may control various genes implicated in pros-
tatic disease, and Shh may be a factor involved in Nkx3.1
expression during postnatal prostatic epithelial growth or in
prostatic disease. In addition to developmental defects,
Nkx3.1 mutant mice develop lesions reminiscent of PIN
(Bhatia-Gaur et al., 1999; Kim et al., 2002), as in our T
Cy cultured VPs. Thus, it is possible that the PIN-like
lesions observed in VPs grown T Cy were due to a loss
of Nkx3.1 expression. Further insight into our PIN-like
lesions could be provided by characterising the effects of Cy
on prostates in vivo, and investigating possible links be-
tween other genes implicated in PIN such as Nkx3.1 (Bha-
tia-Gaur et al., 1999), Rxr (Huang et al., 2002), and Fgf8
(Song et al., 2002) that have been proposed to regulate or be
regulated by Shh.
In conclusion, we have demonstrated that SHH-signal-
ling is not critical for prostatic induction, but plays impor-
tant roles in prostatic growth, branching morphogenesis,
and epithelial differentiation. Inhibition of SHH-signalling
during prostatic growth in vitro led to precocious and ab-
errant differentiation of epithelial cells, resulting in lesions
akin to human cribiform PIN.
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